Item 5.07 Submission of Matters to a Vote of Security Holders.


--------------------------------------------------------------------------------

On June 10, 2022, Ginkgo Bioworks Holdings, Inc. (the "Company") held its 2022 annual meeting of shareholders (the "Annual Meeting"). A total of 859,915,040 shares of Class A common stock and 351,470,842 shares of Class B common stock were present or represented by proxy at the Annual Meeting, representing approximately 81.47% of shares of Class A common stock and Class B common stock, entitled to vote as a single class at the Annual Meeting, and representing approximately 89.15% of shares of Class B common stock entitled to vote as a separate class at the Annual Meeting. The shareholders voted on the matters presented at the Annual Meeting, and the shares present, in person or by proxy, were voted as follows:



1. Election of Directors

Proposal one was the election of eight nominees to serve as directors of the Company, each until the next annual meeting of shareholders or until his or her successor shall have been elected and qualified. Holders of the Class B common stock, voting as a separate class, voted upon two nominees designated to be elected by the holders of Class B common stock. Holders of the Class A common stock and Class B common stock, voting together as a single class, with holders of Class A common stock having one (1) vote per share and holders of Class B common stock having ten (10) votes per share, voted upon six nominees designated to be elected by the holders of Class A common stock and Class B common stock. The results of the vote were as follows:

Director nominees designated to be elected by holders of Class B common stock:

Nominee Votes For Votes Against Abstentions Broker Non-Votes

Jason Kelly 3,500,027,740 1,713,590 89,660 83,307,825 Reshma Shetty 3,501,741,330 0 89,660 83,307,825

Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class):




     Nominee         Votes For   Votes Against Abstentions Broker Non-Votes
 Arie Belldegrun   4,265,404,820  20,950,336    4,960,479     83,307,825
  Marijn Dekkers   4,247,476,853  37,671,449    6,167,333     83,307,825

Christian Henry 4,216,746,933 68,285,199 6,283,503 83,307,825 Reshma Kewalramani 4,279,639,873 8,544,857 3,130,905 83,307,825


   Shyam Sankar    4,211,195,619  76,589,081    3,530,935     83,307,825
  Harry E. Sloan   4,229,850,736  51,996,730    9,468,169     83,307,825

Pursuant to the foregoing votes, the eight nominees listed above were elected to serve on the Company's Board of Directors. There were no additional director nominations brought before the meeting.

2. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm

Proposal two was the ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022, designated to be voted upon by the holders of Class A common stock and Class B Common stock, voting together as a single class, with holders of Class A Stock having one (1) vote per share and holders of Class B Stock having ten (10) votes per share. The results of the vote were as follows:

Votes For Votes Against Abstentions Broker Non-Votes 4,365,263,156 5,152,427 4,207,877 0

Pursuant to the foregoing vote, the ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022 was approved.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses